COVID-19 검출 키트 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 샘플 유형별, 모드별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

COVID-19 Detection Kits Market Size, Share & Trends Analysis Report By Product (RT-PCR Assay Kits), By Sample Type (Nasopharyngeal), By Mode (Centralized Testing), By End-use (Laboratories), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,407,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,820,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,646,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

COVID-19 검출 키트 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, COVID-19 검출 키트 세계 시장 규모는 2030년까지 40억 6,000만 달러에 달할 것으로 예상됩니다.

예측 기간 동안 -4.6%의 CAGR을 기록할 것으로 예상되며, COVID-19 팬데믹은 전 세계 의료 시스템에 몇 가지 도전과제를 제기하고 있습니다. 진단 분야는 팬데믹의 확산을 막고 전 세계에 미치는 악영향을 피하기 위한 노력의 주요 요소 중 하나로 인식되고 있습니다. 이에 따라 기업들은 키트, 시약 및 가정용 검사에 대한 수요를 충족시키기 위해 생산 공정을 늘리고 시장 수익을 늘리고 있습니다.

검사 재료의 부족과 함께 더 짧은 시간 내에 결과를 얻을 수 있는 신속 진단 검사에 대한 수요가 지속적으로 증가하면서 항체 및 항원 검사 키트의 개발이 활발하게 이루어지고 있습니다. 예를 들어, Abbott Laboratories는 2020년 8월 15분 만에 결과를 얻을 수 있는 COVID-19 휴대용 항원 검사에 대한 승인을 받았습니다.

시간과 비용 문제에도 불구하고, 분자 분석은 높은 민감도와 특이성으로 인해 여전히 주요 검출 방법입니다. 그 결과, RT-PCR 기반 분자 분석용 키트는 전 세계적으로 수요가 급증하고 있습니다. 분자 검사 키트의 출하량이 지속적으로 증가하고 있는 것은 이 키트에 대한 높은 수요를 보여줍니다. 예를 들어, 2020년 5월 지멘스 헬시니어스(Siemens Healthineers)는월 250만 개 이상의 분자 PCR 검사 키트를 출하할 계획을 발표했습니다.

COVID-19 검출 키트 시장 보고서 하이라이트:

• RT-PCR 어세이 키트는 PCR 검사의 높은 사용률로 인해 주요 수익 점유율을 차지할 것으로 추정됩니다. 검사 결과의 높은 신뢰성은 전 세계적으로 RT-PCR 분석이 채택되는 주요 요인입니다.
• 비인두(NP) 면봉은 RT-PCR 분석이 NP 면봉에 의존하기 때문에 가장 큰 수익 점유율을 차지할 것으로 추정됩니다. 의료 기관 및 검사 서비스 제공 업체는 시장 진입 기업과 협력하여 환자를 대규모로 검사하기 위해 NP 면봉을 공급하고 있습니다.
• 집중 검사(Non-PoC)는 현재 주요 검사 모드이며 2020년까지 그 우위를 유지할 것으로 예상됩니다. 이 모드를 통해 의료 전문가들은 고도로 자동화된 방식으로 대량의 검체를 매우 효율적으로 처리할 수 있으며, 이는 이 부문의 성장을 주도하고 있습니다.
• 현재 시장에서 실험실은 주요 수익을 창출하는 최종사용자 분야이며, 많은 검사 프로세스가 실험실에서 이루어지고 있습니다.
• 아시아태평양이 높은 확진자 수와 검사 건수로 인해 예측 기간 동안 우위를 유지할 것으로 예상됩니다. 아시아 국가들은 감염 확산을 막기 위한 비용 효율적인 전략으로 신속 항원 검사에 집중하고 있으며, 그 결과 이 지역의 수익이 증가하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 COVID-19 검출 키트 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• COVID-19 검출 키트 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 파이프라인 분석

제4장 COVID-19 검출 키트 시장 : 제품별 추정·동향 분석

• 세계의 COVID-19 검출 키트 시장 : 제품 대시보드
• 세계의 COVID-19 검출 키트 시장 : 제품 변동 분석
• 세계의 COVID-19 검출 키트 시장 매출 : 제품별
• RT-PCR 어세이 키트
• 면역측정 시험지/카세트

제5장 COVID-19 검출 키트 시장 : 샘플별 추정·동향 분석

• 세계의 COVID-19 검출 키트 시장 : 샘플 대시보드
• 세계의 COVID-19 검출 키트 시장 : 샘플 변동 분석
• 세계의 COVID-19 검출 키트 시장 매출 : 샘플별
• 비인두(NP) 스왑
• 구강인두(OP) 스왑
• 비강 스왑
• 기타

제6장 COVID-19 검출 키트 시장 : 모드별 추정·동향 분석

• 세계의 COVID-19 검출 키트 시장 : 모드 대시보드
• 세계의 COVID-19 검출 키트 시장 : 모드 변동 분석
• 세계의 COVID-19 검출 키트 시장 매출 : 모드별
• 분산형 또는 Point of Care(PoC) 테스트
• 집중 테스트(비PoC)

제7장 COVID-19 검출 키트 시장 : 최종 용도별 추정·동향 분석

• 세계의 COVID-19 검출 키트 시장 : 최종 용도 대시보드
• 세계의 COVID-19 검출 키트 시장 : 최종 용도 변동 분석
• 세계의 COVID-19 검출 키트 시장 매출 : 최종 용도별
• 연구소
• 병원
• 진단 센터와 클리닉
• 기타

제8장 COVID-19 검출 키트 시장 : 제품, 샘플, 모드, 최종 용도별 지역 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2020년에서 2030년 :
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제9장 경쟁 상황

• 기업/경쟁 분류
• 벤더 상황
  • 주요 판매대리점 및 채널 파트너 리스트
  • 주요 고객
  • 주요 기업의 시장 점유율 분석, 2023년
  • F. Hoffmann-La Roche AG
  • Perkin Elmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • Veredus Laboratories
  • DiaSorin
  • Altona Diagnostics GmbH
  • Mylab Discovery Solutions Pvt Ltd.
  • Abbott
  • Luminex Corporation
  • Ouidel Corporation

ksm

영문 목차

영문목차

COVID-19 Detection Kits Market Growth & Trends:

The global COVID-19 detection kits market size is expected to reach USD 4.06 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a -4.6% CAGR over the forecast period. The COVID-19 pandemic has posed several challenges to the global healthcare systems. The diagnostics area is recognized as one of the primary elements of efforts to contain the spread and circumvent its adverse impact globally. As a result, companies are ramping up their production process to meet the demand or kits and reagents as well as at-home tests, thereby driving the market revenue.

Constantly increasing demand for rapid diagnostic tests that can deliver results in less time coupled with a shortage of testing materials has triggered the development of antibody and antigen test kits. For instance, in August 2020, Abbott Laboratories secured approval for a COVID-19 portable antigen test that can deliver results in 15 minutes.

Despite the time and cost-related challenges, molecular assay remains the key detection method owing to high sensitivity and specificity. As a result, the kits for RT-PCR based molecular assay are witnessing a huge rise in demand across the globe. The continuous growth in the shipping of the molecular test kit depicts the high demand for these kits. For instance, in May 2020, Siemens Healthineers announced its plans to ship more than 2.5 million molecular PCR test kits per month.

COVID-19 Detection Kits Market Report Highlights:

• RT-PCR assay kits are estimated to account for the major revenue share owing to the high usage rate of PCR testing. High reliability of test results is the key contributing factor of high adoption of RT-PCR assays across the globe
• Nasopharyngeal (NP) swabs are estimated to capture maximum revenue share owing to the dependence of RT-PCR assays on NP swabs. Healthcare institutes and testing service providers have collaborated with market participants for the supply of NP swabs to test patients at a large scale
• Centralized testing (Non-PoC) is currently the key mode of testing and thus it is anticipated to maintain its dominance through 2020. Through this mode, healthcare professionals can process a massive number of samples with great efficiency and a high level of automation, thereby driving the segment growth
• In the current market, laboratories is the key revenue-generating end-user segment with a high number of a testing process taking place within laboratory settings
• With a high number of cases and testing, Asia Pacific is anticipated to maintain its dominance throughout the forecast period. Asian countries are focusing on rapid antigen testing as a cost-effective strategy to contain the spread, resulting in the revenue growth of this region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Sample
  • 1.2.3. Mode
  • 1.2.4. End Use
  • 1.2.5. Regional Scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Sample outlook
  • 2.2.3. Mode outlook
  • 2.2.4. End - use Outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. COVID-19 Detection Kits Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increase in the incidence of COVID-19 globally
    • 3.2.1.2. Increasing approvals of immunoassay tests by regulatory agencies
    • 3.2.1.3. Ongoing seroprevalence surveys to asses the infection rate
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Decreased demand for testing as pandemic recedes globally
• 3.3. COVID-19 Detection Kits Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. COVID-19 Detection Kits Market: Product Estimates & Trend Analysis

• 4.1. Global COVID-19 Detection Kits Market: Product Dashboard
• 4.2. Global COVID-19 Detection Kits Market: Product Movement Analysis
• 4.3. Global COVID-19 Detection Kits Market by Product, Revenue
• 4.4. RT - PCR Assay Kits
  • 4.4.1. RT - PCR Assay Kits market estimates and forecasts 2020 to 2030 (USD Million)
• 4.5. Immunoassay Test Strips/ Cassettes
  • 4.5.1. Immunoassay Test Strips/ Cassettes market estimates and forecasts 2020 to 2030 (USD Million)

Chapter 5. COVID-19 Detection Kits Market: Sample Estimates & Trend Analysis

• 5.1. Global COVID-19 Detection Kits Market: Sample Dashboard
• 5.2. Global COVID-19 Detection Kits Market: Sample Movement Analysis
• 5.3. Global COVID-19 Detection Kits Market Estimates and Forecasts, By Sample, Revenue (USD Million)
• 5.4. Nasopharyngeal (NP) swab
  • 5.4.1. Nasopharyngeal (NP) swab market estimates and forecasts 2020 to 2030 (USD Million)
• 5.5. Oropharyngeal (OP) swab
  • 5.5.1. Oropharyngeal (OP) swab market estimates and forecasts 2020 to 2030 (USD Million)
• 5.6. Nasal Swabs
  • 5.6.1. Nasal Swabs market estimates and forecasts 2020 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts 2020 to 2030 (USD Million)

Chapter 6. COVID-19 Detection Kits Market: Mode Estimates & Trend Analysis

• 6.1. Global COVID-19 Detection Kits Market: Mode Dashboard
• 6.2. Global COVID-19 Detection Kits Market: Mode Movement Analysis
• 6.3. Global COVID-19 Detection Kits Market Estimates and Forecasts, by Mode, Revenue (USD Million)
• 6.4. Decentralized or Point - of - care (PoC) Testing
  • 6.4.1. Decentralized or Point - of - care (PoC) Testing market estimates and forecasts 2020 to 2030 (USD Million)
• 6.5. Centralized Testing (Non - PoC)
  • 6.5.1. Centralized Testing (Non - PoC) market estimates and forecasts 2020 to 2030 (USD Million)

Chapter 7. COVID-19 Detection Kits Market: End Use Estimates & Trend Analysis

• 7.1. Global COVID-19 Detection Kits Market: End Use Dashboard
• 7.2. Global COVID-19 Detection Kits Market: End Use Movement Analysis
• 7.3. Global COVID-19 Detection Kits Market Estimates and Forecasts by End Use, Revenue (USD Million)
• 7.4. Laboratories
  • 7.4.1. Laboratories market estimates and forecasts 2020 to 2030 (USD Million)
• 7.5. Hospitals
  • 7.5.1. Hospitals market estimates and forecasts 2020 to 2030 (USD Million)
• 7.6. Diagnostic Centers and Clinics
  • 7.6.1. Diagnostic Centers and Clinics market estimates and forecasts 2020 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2020 to 2030 (USD Million)

Chapter 8. COVID-19 Detection Kits Market: Regional Estimates & Trend Analysis by Product, Sample, Mode and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2020 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2020 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2020 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2020 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2020 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2020 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2020 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Vendor Landscape
  • 9.2.1. List of key distributors and channel partners
  • 9.2.2. Key customers
  • 9.2.3. Key company market share analysis, 2023
  • 9.2.4. F. Hoffmann-La Roche AG
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Perkin Elmer, Inc.
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Thermo Fisher Scientific, Inc.
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Veredus Laboratories
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. DiaSorin
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Altona Diagnostics GmbH
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Mylab Discovery Solutions Pvt Ltd.
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Abbott
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12. Luminex Corporation
    • 9.2.12.1. Company overview
    • 9.2.12.2. Financial performance
    • 9.2.12.3. Product benchmarking
    • 9.2.12.4. Strategic initiatives
  • 9.2.13. Ouidel Corporation
    • 9.2.13.1. Company overview
    • 9.2.13.2. Financial performance
    • 9.2.13.3. Product benchmarking
    • 9.2.13.4. Strategic initiatives

관련자료